Condition
Systemic Therapy clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Systemic Therapy clinical trials that are recruiting, at sites in 3 countries (most in China (5), United States (1), Vietnam (1)). By phase: Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 3Countries
Newest Systemic Therapy clinical trials
All recruiting trials (7)
-
Omitting brain metastasis radiation after tumor removal when CNS-active therapy is used
This pilot study tests whether patients with resected brain metastases from melanoma or NSCLC can skip post-operative brain radiation while receiving CNS-active systemic therapy.
-
Comparing radiotherapy with early switch to second-line therapy for oligoprogressive HCC
This study is testing whether adding radiotherapy to ongoing treatment helps people with hepatocellular carcinoma who have limited cancer growth, compared to switching to a different treatment sooner.
-
Collecting data on treatment effectiveness and safety for patients with advanced liver cancer
This study is testing how well a combination of a specific cancer treatment and immunotherapy works for patients with advanced liver cancer who haven't been treated before or have had their cancer come back.
-
Removing most of the stomach tumor after chemotherapy versus chemotherapy alone for limited metastatic stomach cancer
This trial will test whether removing most of the stomach tumor after initial systemic therapy helps people with limited metastatic stomach cancer live longer than systemic therapy alone.
-
Ablation therapy for lung metastases in advanced liver cancer
This study tests whether a new treatment combining image-guided ablation therapy with standard care can help people with advanced liver cancer that has spread to the lungs feel better and live longer.
-
Combining TIPS with Lenvatinib and PD-1 inhibitors for advanced liver cancer with portal vein tumor thrombus
This study is testing if combining a special procedure with two cancer treatments can help people with advanced liver cancer and a serious blood clot in the portal vein feel better and have better results.
-
Comparing TACE-Lenvatinib with TACE-Lenvatinib-ablation for recurrent liver cancer
This study is testing if adding ablation to the combination of TACE and Lenvatinib can help people with recurrent liver cancer feel better compared to just using TACE and Lenvatinib alone.
Related topics
Quick answers
How many Systemic Therapy clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (5 trials), United States (1 trial), Vietnam (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.